{"uniprot":"Q9H8Q6","gene":"HEXA-AS1","name":"Putative uncharacterized protein encoded by HEXA-AS1","organism":"Homo sapiens (Human)","status":"dark","length":139,"sequence":"MTGKNVYFQSQLEAFHCLQYELFPSRLTINLLVTTHIPFPQTKPHIARCVFTESSKILLGLWVQDGECSEIMTGAWSCRALRRKSRNLFSEQLKIIPKDLHFRNTMLSSCIRNQLGGPFLLEVENNERLNYRSGEGRQL","function_summary":"A cytosolic regulatory scaffold that uses multivalent protein binding to assemble and stabilize transcription-repressive complexes. By buffering and organizing transcription factors and corepressors in the cytoplasm, it modulates their trafficking and availability, thereby attenuating gene expression programs. Its soluble localization supports dynamic complex assembly that ultimately enforces negative regulation of transcription.","plain_language":"HEXA-AS1 has barely been studied. The model's best guess: A cytosolic regulatory scaffold that uses multivalent protein binding to assemble and stabilize transcription-repressive complexes. By buffering and organizing transcription factors and corepressors in the cytoplasm, it modulates their trafficking and availability, thereby attenuating gene expression programs.","uniprot_summary":"May be involved in transcriptional regulation.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0045892","label":"negative regulation of DNA-templated transcription"}],"cellular_component":[{"id":"GO:0005829","label":"cytosol"}]},"interpro":[],"reasoning":"I begin with the InterPro architecture. The sequence carries a single annotated module: GO:0005515 protein binding as a basal capability. The absence of catalytic InterPro signatures and the presence of a generic binding annotation point toward a non-enzymatic regulator that operates through multivalent protein–protein interactions rather than direct catalysis. Such architectures typically stabilize transcriptional assemblies or recruit corepressors.\n\nFrom this binding-centric core, I infer molecular function first. A protein whose primary capability is protein binding and that is embedded in transcriptional control circuits most parsimoniously acts as a scaffold or adaptor that modulates other macromolecules’ activities. This binding capacity provides the mechanistic basis for assembling or stabilizing regulatory complexes.\n\nThat binding role causally links to transcriptional outcomes. The biological process label GO:0045892 negative regulation of DNA-templated transcription fits the mechanistic profile: a cytosolic binding platform that tunes transcription indirectly by recruiting corepressors or by controlling the availability and assembly of transcriptional machinery. The explicit note that it may be involved in transcriptional regulation aligns with this causal chain—binding leads to complex assembly, which leads to repression of transcriptional output.\n\nCellular localization resolves the spatial logic. GO:0005829 cytosol and broader cytoplasmic residence indicate that this regulator operates before or during nucleo-cytoplasmic shuttling. A cytosolic scaffold can sequester transcription factors or chromatin-modifying enzymes, gate their nuclear entry, and thereby attenuate transcription. This soluble environment also favors dynamic assembly and disassembly of repression complexes.\n\nPutting these elements together yields a mechanistic hypothesis. The protein functions as a cytosolic adaptor that binds transcription-related factors and corepressor machinery, dampening transcription by controlling complex stoichiometry and timing. It likely associates with transcriptional repressors and chromatin-modifying assemblies—such as histone deacetylase complexes or CtBP/CoREST-like modules—whose cytosolic pools require buffering and delivery. By stabilizing these assemblies and limiting their nuclear flux, the protein enforces negative regulation of gene expression.\n\nFrom this model, I hypothesize interaction partners that match the inferred mechanism: cytosolic transcription factors and their adaptors; corepressor complexes (e.g., HDAC-containing assemblies); and transport or chaperone systems that manage nucleo-cytoplasmic trafficking. These interactions would collectively implement transcriptional repression without requiring intrinsic enzymatic activity.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q9H8Q6.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q9H8Q6"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q9H8Q6/entry","atlas":"/p/Q9H8Q6"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}